Latest Announcements

Popees Baby Care India Ltd has postponed its Board Meeting scheduled for 22 September 2026 to consider a proposal for raising funds through a share swap arrangement. The meeting has been rescheduled to 8 October 2026.

GIC Housing Finance Limited has informed the Exchange about the issue of Secured, Listed, Rated, Redeemable, Taxable, Non-Convertible Debentures 2026-27 Series 12 Tranche 2 on private placement basis.

Apollo Micro Systems Limited has informed the Exchange about General Updates regarding the proposed Preferential Issue of 2,28,30,902 Equity Shares and 5,69,15,380 Equity Warrants, and has clarified the observations received from NSE in relation to the Notice of the Extra Ordinary General Meeting.

Qualitek Labs Ltd has informed the exchange about the issuance of equity shares and fully convertible warrants on a preferential basis. The company has approved the issuance of up to 3,86,000 equity shares and up to 5,20,000 fully convertible warrants to the proposed allottees, including promoters and non-promoters, at an issue price of ₹518.55 per equity share.

GIC Housing Finance Ltd has issued a private placement of Non-Convertible Debentures (NCDs) worth Rs. 200 Crores, with a green shoe option of up to Rs. 100 Crores, on the BSE Limited exchange.

Aditya Infotech Ltd has informed the exchange about a Qualified Institutional Placement (QIP) under Regulation 30 (LODR). The QIP Committee has approved the floor price of ₹3,648.43 per equity share and has fixed the relevant date as September 22, 2026. The company may offer a discount of not more than 5% on the floor price.

Aditya Infotech Limited has informed the Exchange about a qualified institutional placement of equity shares under the provisions of Chapter VI of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and Sections 42 and 62 of the Companies Act, 2013.

Aditya Infotech Ltd has announced the outcome of its QIP Committee meeting, where it has authorized the opening of a qualified institutions placement (QIP) issue, fixed the floor price at ₹3,648.43 per equity share, and determined the relevant date for the purpose of the issue.

Aditya Infotech Limited has informed the Exchange regarding Outcome of QIP Committee Meeting held on September 22, 2026. The QIP Committee has approved the authorization for opening of the Issue, floor price, and preliminary placement document for the Qualified Institutions Placement (QIP) of equity shares.

Canara Bank has uploaded the offering circular on Singapore Stock Exchange (SGX) for its existing medium term note programme.

Canara Bank has informed the Exchange regarding the listing of its offering circular on the Singapore Stock Exchange (SGX) for its existing medium term note programme.

Fredun Pharmaceuticals Ltd has allotted 3,61,599 equity shares to non-promoter allottees pursuant to the conversion of 1,20,533 warrants into equity shares, consequent to the 1:2 bonus issue.

NDA Securities Ltd has withdrawn its proposal to issue 1,70,00,000 equity shares on a preferential basis to promoters and non-promoters due to reasons beyond control.

Kerala Ayurveda Ltd has issued a corrigendum to its AGM notice, revising the number of equity shares proposed to be issued to Katra Holding Private Limited from 7,20,000 to 6,55,000.

Embassy Developments Ltd has announced the allotment of non-convertible debentures aggregating to INR 105 crores on a private placement basis.

Kerala Ayurveda Ltd has issued a corrigendum to its notice of 34th AGM, revising the number of equity shares proposed to be issued to Katra Holding Private Limited under a preferential issue from 7,20,000 to 6,55,000.

Manba Finance Limited has informed the Exchange about increase in Authorised Capital and proposed preferential issue of fully convertible warrants and Equity Shares.

Manba Finance Limited has informed the Exchange about the issue of securities, including an increase in authorized share capital, preferential issue of fully convertible warrants and Equity Shares, and a proposal for a private placement.

Fredun Pharmaceuticals Ltd has allotted 3,61,599 equity shares to non-promoter allottees pursuant to the conversion of 1,20,533 warrants into equity shares, consequent to the 1:2 bonus issue.

Manba Finance Limited has informed the Exchange regarding Outcome of Board Meeting held on September 22, 2026, where the Board approved increase in authorised share capital and preferential issue of fully convertible warrants and Equity Shares.